First Page | Document Content | |
---|---|---|
![]() Chronic lower respiratory diseases Chronic obstructive pulmonary disease Smoking Phosphodiesterase-4 inhibitor Acute exacerbation of chronic obstructive pulmonary disease Roflumilast Spirometry Tiotropium bromide Pulmonology Respiratory therapy Medicine | Add to Reading List |
![]() | Läkemedelsnytt Nr 3 – 18 mars 2011 Daxas (roflumilast): Nygammal farmakologisk princip för behandling av KOL En ny selektiv PDE-hämmareDocID: 1dajE - View Document |
![]() | Briefing Book - April 2010DocID: Gi0Z - View Document |
![]() | FDA ERRATA (dated[removed]To FDA Advisory Committee Briefing Documents PULMONARY-ALLERGY DRUGS ADVISORY COMMITTEE MEETING April 7, 2010 NDA[removed]: Daxas (roflumilast 500 mcg tablets)DocID: G9xY - View Document |
![]() | Daxas® (roflumilast) Tablets NDA[removed]Pulmonary-Allergy Drugs Advisory Committee Meeting April 7, 2010DocID: FTyj - View Document |
![]() | Q&A Slides Presented FDA PADAC Pulmonary-Allergy Drugs Advisory Committee Meeting April 7, 2010DocID: FPD3 - View Document |